Latest Expert Opinions

Signal
Opinion
Expert
COMMENT
COMMENT
June 14, 2019
Is there any growth in the investment business? AGF's balance sheet is too big for what they earn. Potential write-offs must happen to bring that down. Asset management businesses are being killed. $10.84 is his target price--lots of upside and they can cover their dividend.
Show full opinionHide full opinion
Is there any growth in the investment business? AGF's balance sheet is too big for what they earn. Potential write-offs must happen to bring that down. Asset management businesses are being killed. $10.84 is his target price--lots of upside and they can cover their dividend.
BUY WEAKNESS
BUY WEAKNESS
June 14, 2019
$45.27 is his model price, and it's close to this. He would buy at $41.
Show full opinionHide full opinion
Enbridge (ENB-T)
June 14, 2019
$45.27 is his model price, and it's close to this. He would buy at $41.
DON'T BUY
DON'T BUY
June 14, 2019
It's overvalued relative to its earnings. $38.50 is his model price, far below its current price. Pays a 4.26% yield. Telus can cover its dividend, but it is way too expensive. He would buy at $40, not now.
Show full opinionHide full opinion
Telus Corp (T-T)
June 14, 2019
It's overvalued relative to its earnings. $38.50 is his model price, far below its current price. Pays a 4.26% yield. Telus can cover its dividend, but it is way too expensive. He would buy at $40, not now.
DON'T BUY
DON'T BUY
June 14, 2019
He models only $48.88. It pays a meager dividend. This is way overpriced. Gold is having a good run though, but he holds little gold.
Show full opinionHide full opinion
He models only $48.88. It pays a meager dividend. This is way overpriced. Gold is having a good run though, but he holds little gold.
SELL
SELL
June 14, 2019
Their balance sheet is a mystery. What happened in 2017? Was something spun off? $35.69 is his model price, far below current pricing. He doesn't follow EMA. Their earnings relative to balance sheet are way overpriced (and so are their peers). You had a good ride, so sell it now. This has gone too far, too fast, after hitting an all-time high.
Show full opinionHide full opinion
Emera Inc (EMA-T)
June 14, 2019
Their balance sheet is a mystery. What happened in 2017? Was something spun off? $35.69 is his model price, far below current pricing. He doesn't follow EMA. Their earnings relative to balance sheet are way overpriced (and so are their peers). You had a good ride, so sell it now. This has gone too far, too fast, after hitting an all-time high.
DON'T BUY
DON'T BUY
June 14, 2019
The balance sheet is impaired and there should be write-offs, which he hasn't seen. He sees 32% upside with a $64 model price, but he'd be happy seeing this at $53.80. He would recommend this stock above this price. He has recommended MET before, but MET just can't get going. The balance sheet is ugly. Also, if interest rates fall to zero, all insurance companies will get hit.
Show full opinionHide full opinion
Metlife (MET-N)
June 14, 2019
The balance sheet is impaired and there should be write-offs, which he hasn't seen. He sees 32% upside with a $64 model price, but he'd be happy seeing this at $53.80. He would recommend this stock above this price. He has recommended MET before, but MET just can't get going. The balance sheet is ugly. Also, if interest rates fall to zero, all insurance companies will get hit.
BUY WEAKNESS
BUY WEAKNESS
June 14, 2019
His model price is $24.26, below current prices, but this is book value as he sees it. SNC is interesting now (he's not recommended it before). This is worth a speculation around $23. Wait for a pullback.
Show full opinionHide full opinion
His model price is $24.26, below current prices, but this is book value as he sees it. SNC is interesting now (he's not recommended it before). This is worth a speculation around $23. Wait for a pullback.